Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial

著者: Gianluca Masi, Lisa Salvatore, Luca Boni, Fotios Loupakis, Chiara Cremolini, Lorenzo Fornaro, Marta Schirripa, S. Cupini, C. Barbara, V. Safina, Cristina Granetto, Elena Fea, Lorenzo Antonuzzo, C. Boni, Giacomo Allegrini, S. Chiara, D. Amoroso, Andrea Bonetti, Alfredo Falcone - Annals of Oncology 2015 被引用: 169